These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 23597195)

  • 21. Epigenetic regulation of active Chinese herbal components for cancer prevention and treatment: A follow-up review.
    Huang Z; Huang Q; Ji L; Wang Y; Qi X; Liu L; Liu Z; Lu L
    Pharmacol Res; 2016 Dec; 114():1-12. PubMed ID: 27697644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural Agents-Mediated Targeting of Histone Deacetylases.
    Farooqi AA; Naqvi SK; Perk AA; Yanar O; Tabassum S; Ahmad MS; Mansoor Q; Ashry MS; Ismail M; Naoum GE; Arafat WO
    Arch Immunol Ther Exp (Warsz); 2018 Feb; 66(1):31-44. PubMed ID: 28852775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic perspectives on cancer chemotherapy response.
    Liu MZ; McLeod HL; He FZ; Chen XP; Zhou HH; Shu Y; Zhang W
    Pharmacogenomics; 2014 Apr; 15(5):699-715. PubMed ID: 24798726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
    Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic alterations in cancer and personalized cancer treatment.
    Miozzo M; Vaira V; Sirchia SM
    Future Oncol; 2015; 11(2):333-48. PubMed ID: 25591842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic Targets and their Inhibitors in Cancer Therapy.
    Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
    Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Natural Dietary Compounds and Food-Borne Mycotoxins on DNA Methylation and Cancer.
    Ghazi T; Arumugam T; Foolchand A; Chuturgoon AA
    Cells; 2020 Aug; 9(9):. PubMed ID: 32878338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.
    Gerhauser C
    Top Curr Chem; 2013; 329():73-132. PubMed ID: 22955508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of natural compounds for the targeting and chemoprevention of ovarian cancer.
    Pistollato F; Calderón Iglesias R; Ruiz R; Aparicio S; Crespo J; Dzul Lopez L; Giampieri F; Battino M
    Cancer Lett; 2017 Dec; 411():191-200. PubMed ID: 29017913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions.
    Bouyahya A; Mechchate H; Oumeslakht L; Zeouk I; Aboulaghras S; Balahbib A; Zengin G; Kamal MA; Gallo M; Montesano D; El Omari N
    Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyphenols as Potent Epigenetics Agents for Cancer.
    Rajendran P; Abdelsalam SA; Renu K; Veeraraghavan V; Ben Ammar R; Ahmed EA
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Epigenetic Dietary Components on Cancer through Histone Modifications.
    Gao Y; Tollefsbol TO
    Curr Med Chem; 2015; 22(17):2051-64. PubMed ID: 25891109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting epigenetic regulatory machinery to overcome cancer therapy resistance.
    Guo L; Lee YT; Zhou Y; Huang Y
    Semin Cancer Biol; 2022 Aug; 83():487-502. PubMed ID: 33421619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetics in radiotherapy: where are we heading?
    Smits KM; Melotte V; Niessen HE; Dubois L; Oberije C; Troost EG; Starmans MH; Boutros PC; Vooijs M; van Engeland M; Lambin P
    Radiother Oncol; 2014 May; 111(2):168-77. PubMed ID: 24861629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Autophagy with Natural Products as a Potential Therapeutic Approach for Cancer.
    Al-Bari MAA; Ito Y; Ahmed S; Radwan N; Ahmed HS; Eid N
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic alternations and cancer chemotherapy response.
    Lv JF; Hu L; Zhuo W; Zhang CM; Zhou HH; Fan L
    Cancer Chemother Pharmacol; 2016 Apr; 77(4):673-84. PubMed ID: 26707728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetics and oncology.
    Mummaneni P; Shord SS
    Pharmacotherapy; 2014 May; 34(5):495-505. PubMed ID: 24619798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research.
    Li Y; Kong D; Wang Z; Sarkar FH
    Pharm Res; 2010 Jun; 27(6):1027-41. PubMed ID: 20306121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.